Phadia AB

Phadia AB is a Swedish healthcare company based in Uppsala, specializing in blood test systems for the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases. Established in the mid-1960s, Phadia became an independent entity in 2006 and has been part of Thermo Fisher Scientific since 2011. The company is recognized as a global leader in in vitro allergy diagnostics and a prominent player in autoimmunity diagnostics. Phadia's product portfolio includes the ImmunoCAP® brand for allergy testing and the EliA™ brand for autoimmunity testing. The company supplies a significant portion of allergy laboratory tests worldwide and offers advanced diagnostic services, including traditional extract-based tests and innovative molecular allergology. This approach allows for detailed insights into allergic reactions and patient suitability for immunotherapies. Phadia serves clinical laboratories, hospitals, and healthcare providers in over 20 countries, employing around 1,300 to 1,500 people globally.

• Employees 80